Abstract
Association of Cytokine Proteins with Disease Activity in Neuromyelitis Optica Spectrum Disorder Participants Receiving Inebilizumab Treatment (S32.005)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have